slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
37.300 KRW | +2,05% | +9,87% | -15,80% |
Vakgebied
Aantal werknemers: 306
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 109 995 | 100,0 % | 134 910 | 100,0 % | +22,65% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
99,9
%
| 109 960 | 100,0 % | 134 839 | 99,9 % | +22,63% |
International
0,1
%
| 36 | 0,0 % | 71 | 0,1 % | +97,61% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Su-jin Park
CEO | Chief Executive Officer | - | 29-03-23 |
Seung-Kook Park
CEO | Chief Executive Officer | 61 | - |
Seung-Won Jeong
BRD | Director/Board Member | 53 | 01-03-21 |
Sung-Yeon Im
BRD | Director/Board Member | 55 | - |
Beom-Kyu Son
PRN | Corporate Officer/Principal | 56 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jae-Chun Yoon
BRD | Director/Board Member | 64 | 30-07-15 |
Seung-Kook Park
CEO | Chief Executive Officer | 61 | - |
Sung-Yeon Im
BRD | Director/Board Member | 55 | - |
Jin-Hyoung Kim
BRD | Director/Board Member | 47 | 18-03-16 |
Cheol-Heon Lee
BRD | Director/Board Member | 50 | - |
Jung-Kyu Lee
BRD | Director/Board Member | 61 | - |
Heon Jeong
BRD | Director/Board Member | 48 | - |
Seung-Won Jeong
BRD | Director/Board Member | 53 | 01-03-21 |
Almira Chabi
BRD | Director/Board Member | - | 24/11 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 52 240 638 | 30 678 163 ( 58,72 %) | 1 544 521 ( 2,957 %) | 58,72 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
1 547 521 | 2.96% | 40 420 738 $ |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,80% | 1,38 mld. | |
+32,09% | 694 mld. | |
+29,39% | 593 mld. | |
-1,34% | 371 mld. | |
+20,34% | 331 mld. | |
+7,39% | 290 mld. | |
+14,25% | 239 mld. | |
-3,03% | 209 mld. | |
+10,02% | 209 mld. | |
+8,49% | 169 mld. |
- Beurs
- Aandelen
- Koers A009420
- Onderneming Hanall Biopharma Co., Ltd.